IL231637A0 - Recombinant f rsv nano-particle vaccine for respiratory syncytial virus - Google Patents
Recombinant f rsv nano-particle vaccine for respiratory syncytial virusInfo
- Publication number
- IL231637A0 IL231637A0 IL231637A IL23163714A IL231637A0 IL 231637 A0 IL231637 A0 IL 231637A0 IL 231637 A IL231637 A IL 231637A IL 23163714 A IL23163714 A IL 23163714A IL 231637 A0 IL231637 A0 IL 231637A0
- Authority
- IL
- Israel
- Prior art keywords
- rsv
- vaccine
- respiratory syncytial
- syncytial virus
- nanoparticle
- Prior art date
Links
- 241000725643 Respiratory syncytial virus Species 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/115—Paramyxoviridae, e.g. parainfluenza virus
- C07K14/135—Respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161542040P | 2011-09-30 | 2011-09-30 | |
| US201161542721P | 2011-10-03 | 2011-10-03 | |
| US201261611834P | 2012-03-16 | 2012-03-16 | |
| US201261614286P | 2012-03-22 | 2012-03-22 | |
| PCT/US2012/057546 WO2013049342A1 (en) | 2011-09-30 | 2012-09-27 | Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL231637A0 true IL231637A0 (en) | 2014-05-28 |
Family
ID=47996397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL231637A IL231637A0 (en) | 2011-09-30 | 2014-03-20 | Recombinant f rsv nano-particle vaccine for respiratory syncytial virus |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20130122032A1 (enExample) |
| EP (1) | EP2760469A4 (enExample) |
| JP (1) | JP2014530010A (enExample) |
| KR (1) | KR20140077169A (enExample) |
| CN (2) | CN104080476A (enExample) |
| AU (1) | AU2013201495B2 (enExample) |
| BR (1) | BR112014007616A2 (enExample) |
| CA (1) | CA2849471A1 (enExample) |
| HK (1) | HK1222125A1 (enExample) |
| IL (1) | IL231637A0 (enExample) |
| MX (1) | MX2014003777A (enExample) |
| RU (1) | RU2014117068A (enExample) |
| SG (2) | SG11201400999VA (enExample) |
| WO (1) | WO2013049342A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2370099T3 (en) | 2008-12-09 | 2016-08-01 | Novavax Inc | Rsv f modified proteins and methods of their use |
| US11446374B2 (en) | 2008-12-09 | 2022-09-20 | Novavax, Inc. | Modified RSV F proteins and methods of their use |
| BR112015025392A2 (pt) * | 2013-04-08 | 2017-10-10 | Medimmune Llc | composição de vacina e método de utilização |
| EP3049107A1 (en) * | 2013-09-24 | 2016-08-03 | Massachusetts Institute of Technology | Self-assembled nanoparticle vaccines |
| CN105087643A (zh) * | 2014-04-16 | 2015-11-25 | 中国科学院上海巴斯德研究所 | 重组表达人呼吸道合胞病毒f1蛋白胞外区的方法及表达系统 |
| WO2015195961A1 (en) * | 2014-06-18 | 2015-12-23 | Georgia State University And Research Foundation, Inc. | Recombinant rsv reporter virus |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| CA2996762A1 (en) * | 2015-08-31 | 2017-03-09 | Technovax, Inc. | Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine |
| JP6975709B2 (ja) * | 2015-09-02 | 2021-12-01 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | 安定化したウイルスクラスｉ融合タンパク質 |
| CN114617959A (zh) | 2015-09-03 | 2022-06-14 | 诺瓦瓦克斯股份有限公司 | 具有改进的稳定性和免疫原性的疫苗组合物 |
| CN106547635B (zh) | 2015-09-18 | 2020-10-09 | 阿里巴巴集团控股有限公司 | 一种作业的操作重试方法和装置 |
| PE20181354A1 (es) | 2015-12-23 | 2018-08-22 | Pfizer | Mutantes de proteina f de rsv |
| KR20220041966A (ko) * | 2016-04-05 | 2022-04-01 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정화된 용해성 융합-전 rsv f 단백질 |
| CN106124767A (zh) * | 2016-05-12 | 2016-11-16 | 广州瑞辉生物科技股份有限公司 | 呼吸道合胞病毒IgA抗体检测试纸条及其检测方法 |
| WO2018067300A1 (en) | 2016-10-03 | 2018-04-12 | University Of Massachusetts | Methods for immunizing pre-immune subjects against respiratory syncytial virus (rsv) |
| EP3595709A4 (en) * | 2017-03-15 | 2020-12-23 | Novavax, Inc. | METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES TO CLOSTRIDIUM DIFFICILE |
| JP7168938B2 (ja) | 2017-04-04 | 2022-11-10 | ユニヴァーシティ オブ ワシントン | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
| CN107050446B (zh) * | 2017-04-19 | 2020-08-11 | 武汉博沃生物科技有限公司 | 经修饰的季节流感-rsv联合疫苗及其制备方法 |
| WO2019023196A1 (en) | 2017-07-24 | 2019-01-31 | Novavax, Inc. | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE |
| WO2019063844A1 (en) * | 2017-09-29 | 2019-04-04 | Universiteit Antwerpen | VACCINATION AGAINST SYNCYTIAL RESPIRATORY VIRUS |
| CA3095216A1 (en) | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
| US11278612B2 (en) | 2018-03-19 | 2022-03-22 | Novavax, Inc. | Multivalent influenza nanoparticle vaccines |
| KR102567994B1 (ko) * | 2018-10-12 | 2023-08-17 | 에스케이바이오사이언스(주) | 재조합 rsv 생백신주 및 이의 제조 방법 |
| WO2020092365A1 (en) * | 2018-10-29 | 2020-05-07 | Binh Ha | Rsv virus-like particles and methods of use thereof |
| KR102725189B1 (ko) * | 2018-11-01 | 2024-10-31 | 에스케이바이오사이언스(주) | 재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물 |
| CN113543803B (zh) * | 2019-02-28 | 2024-10-29 | Km生物医药股份公司 | Rsv f/g嵌合疫苗 |
| CN110229219B (zh) * | 2019-06-21 | 2021-03-30 | 中国科学院武汉病毒研究所 | 一种新型的呼吸道合胞病毒疫苗抗原的制备方法及其用途 |
| EP4097123A4 (en) * | 2020-01-27 | 2024-02-14 | Novavax, Inc. | CORONAVIRUS VACCINE FORMULATIONS |
| US10953089B1 (en) | 2020-01-27 | 2021-03-23 | Novavax, Inc. | Coronavirus vaccine formulations |
| WO2021198413A1 (en) * | 2020-04-02 | 2021-10-07 | Janssen Vaccines & Prevention B.V. | Stabilized vaccine compositions |
| CN113855796B (zh) * | 2021-07-30 | 2024-01-26 | 河北医科大学 | 卡介苗作为呼吸道合胞病毒灭活疫苗佐剂的应用 |
| TW202330922A (zh) * | 2021-11-19 | 2023-08-01 | 美商Ｒｎａ免疫公司 | 核糖核酸呼吸道融合病毒(rsv)疫苗之組合物及方法 |
| KR102785012B1 (ko) * | 2021-12-14 | 2025-03-20 | 경희대학교 산학협력단 | Rsv 항원 단백질을 포함하는 바이러스 유사입자 및 이를 이용한 백신 |
| TW202417469A (zh) * | 2022-09-01 | 2024-05-01 | 美商諾瓦瓦克斯股份有限公司 | 純化供用於疫苗組成物之具有疏水性膜結構域的病毒蛋白的下游程序 |
| CN117986382B (zh) * | 2022-11-04 | 2025-04-01 | 北京康乐卫士生物技术股份有限公司 | 针对rsv的重组亚单位疫苗及其应用 |
| WO2024259624A1 (en) * | 2023-06-21 | 2024-12-26 | Shenzhen Genius Biotech Service Co. Ltd | A modified rsv f protein, a nanoparticle, a composition and a vaccine against respiratory syncytial virus infection |
| WO2024260446A1 (zh) * | 2023-06-21 | 2024-12-26 | 深圳深信生物科技有限公司 | 呼吸道合胞病毒(rsv)疫苗 |
| WO2025026448A1 (zh) * | 2023-08-03 | 2025-02-06 | 广州穗和生物技术有限公司 | 修饰的呼吸道合胞病毒f蛋白及其用途 |
| CN119569835A (zh) * | 2023-09-07 | 2025-03-07 | 北京科兴中维生物技术有限公司 | 呼吸道合胞病毒f蛋白及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006524511A (ja) * | 2003-04-25 | 2006-11-02 | メッドイミューン バクシーンズ，インコーポレイティド | メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン |
| EP2181121A4 (en) * | 2007-03-21 | 2012-07-11 | Id Biomedical Corp Quebec | CHIMÄRE ANTIGENE |
| CN101801411A (zh) * | 2007-07-19 | 2010-08-11 | 诺瓦瓦克斯股份有限公司 | 嵌合水痘带状疱疹病毒病毒样颗粒 |
| SI2222710T1 (sl) * | 2007-12-24 | 2016-11-30 | Id Biomedical Corporation Of Quebec | Rekombinatni RSV antigeni |
| EP2254554A1 (en) * | 2008-02-25 | 2010-12-01 | Novavax, Inc. | Sugar glassified virus like particles (vlps) |
| KR101027159B1 (ko) * | 2008-07-28 | 2011-04-05 | 뮤추얼아이피서비스(주) | 타겟 영상 검출 장치 및 그 방법 |
| DK2370099T3 (en) * | 2008-12-09 | 2016-08-01 | Novavax Inc | Rsv f modified proteins and methods of their use |
| WO2010077712A1 (en) * | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Bovine respiratory syncytial virus virus-like particle (vlps) |
-
2012
- 2012-09-27 AU AU2013201495A patent/AU2013201495B2/en not_active Ceased
- 2012-09-27 US US13/629,107 patent/US20130122032A1/en not_active Abandoned
- 2012-09-27 JP JP2014533316A patent/JP2014530010A/ja active Pending
- 2012-09-27 CN CN201280059282.1A patent/CN104080476A/zh active Pending
- 2012-09-27 SG SG11201400999VA patent/SG11201400999VA/en unknown
- 2012-09-27 EP EP12835033.7A patent/EP2760469A4/en not_active Withdrawn
- 2012-09-27 CA CA2849471A patent/CA2849471A1/en not_active Abandoned
- 2012-09-27 SG SG10201602434UA patent/SG10201602434UA/en unknown
- 2012-09-27 MX MX2014003777A patent/MX2014003777A/es unknown
- 2012-09-27 WO PCT/US2012/057546 patent/WO2013049342A1/en not_active Ceased
- 2012-09-27 RU RU2014117068/10A patent/RU2014117068A/ru not_active Application Discontinuation
- 2012-09-27 BR BR112014007616A patent/BR112014007616A2/pt active Search and Examination
- 2012-09-27 CN CN201510769961.3A patent/CN105381457A/zh active Pending
- 2012-09-27 KR KR1020147009538A patent/KR20140077169A/ko not_active Withdrawn
-
2014
- 2014-03-20 IL IL231637A patent/IL231637A0/en unknown
-
2015
- 2015-02-27 US US14/634,162 patent/US20150335730A1/en not_active Abandoned
- 2015-02-27 US US14/634,171 patent/US20150306207A1/en not_active Abandoned
-
2016
- 2016-08-31 HK HK16110329.3A patent/HK1222125A1/zh unknown
-
2017
- 2017-02-15 US US15/433,759 patent/US20170319682A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014003777A (es) | 2015-05-15 |
| BR112014007616A2 (pt) | 2017-04-04 |
| WO2013049342A1 (en) | 2013-04-04 |
| US20150335730A1 (en) | 2015-11-26 |
| CN104080476A (zh) | 2014-10-01 |
| US20130122032A1 (en) | 2013-05-16 |
| CA2849471A1 (en) | 2013-04-04 |
| JP2014530010A (ja) | 2014-11-17 |
| EP2760469A1 (en) | 2014-08-06 |
| SG10201602434UA (en) | 2016-05-30 |
| RU2014117068A (ru) | 2015-11-10 |
| US20150306207A1 (en) | 2015-10-29 |
| AU2013201495B2 (en) | 2015-12-03 |
| CN105381457A (zh) | 2016-03-09 |
| US20170319682A1 (en) | 2017-11-09 |
| SG11201400999VA (en) | 2014-07-30 |
| KR20140077169A (ko) | 2014-06-23 |
| HK1222125A1 (zh) | 2017-06-23 |
| AU2013201495A1 (en) | 2013-04-18 |
| EP2760469A4 (en) | 2015-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL231637A0 (en) | Recombinant f rsv nano-particle vaccine for respiratory syncytial virus | |
| SG10201801431TA (en) | Respiratory syncytial virus (rsv) vaccine | |
| GB2490507B (en) | Respiratory mask | |
| AP2014007993A0 (en) | Vaccine against RSV | |
| IL239284B (en) | Nasal flu vaccine compound | |
| PT2806891T (pt) | Vacinas baseadas no vírus parainfluenza 5 | |
| ZA201404516B (en) | Vaccines against hpv | |
| ZA201304117B (en) | Compounds for treating respiratory syncytial virus infections | |
| ZA201405177B (en) | Vesicular stomatitis virus for prime boost vaccines | |
| PH12013502174A1 (en) | Vaccine delivery method | |
| EP2753354A4 (en) | SUB-VACCINE IN NANOEMULSION FORM FOR RESPIRATORY SYNZYTIAL VIRUS | |
| PL2755680T3 (pl) | Preparaty szczepionkowe w postaci cząstek | |
| IL221320A0 (en) | Compounds for treating respiratory syncytial virus infections | |
| AU340029S (en) | Respiratory mask | |
| HUP1100470A2 (en) | Nanoparticle-based veterinary vaccine | |
| EP2739629A4 (en) | COMPOUNDS FOR THE TREATMENT OF SYNCYTIAL RESPIRATORY VIRUS INFECTIONS | |
| HK1197730A (en) | Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus | |
| TWM432433U (en) | Respiratory nasal tube | |
| ZA201406890B (en) | Vaccine against rsv | |
| GB201108986D0 (en) | Vaccines | |
| GB201108984D0 (en) | Vaccines | |
| GB201108982D0 (en) | Vaccines |